Racial and ethnic disparities in treatment-related heart disease mortality among US breast cancer survivors
Jacqueline B. Vo(National Institutes of Health), Amy Berrington de González(Institute of Cancer Research), Ana Barac(Inova Fairfax Hospital), Cody Ramin(Cedars-Sinai Medical Center), Lene H. S. Veiga(National Cancer Institute), Wayne R. Lawrence(Albany State University), Katherine L. Ho(Yale University), Jongeun Rhee(Uniformed Services University of the Health Sciences)
Cited by 15
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767